Gene · 3914
Papers1,750
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,750
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anoikis-related genes in breast cancer patients: reliable biomarker of prognosis. | BMC Cancer | 2024 | 39300389 | PubTator, text mining | PubMed |
| Integrative genomics unveils basement membrane-related diagnostic markers and therapeutic targets in esophageal squamous cell carcinoma. | Biol Direct | 2024 | 39256753 | PubTator, text mining | PubMed |
| Potential regulation and prognostic model of colorectal cancer with extracellular matrix genes. | Heliyon | 2024 | 39247375 | PubTator, text mining | PubMed |
| Identification of LINC02454-related key pathways and genes in papillary thyroid cancer by weighted gene coexpression network analysis (WGCNA). | Thyroid Res | 2024 | 39218967 | PubTator, text mining | PubMed |
| The LAMB3-EGFR signaling pathway mediates synergistic Anti-Cancer effects of berberine and emodin in Pancreatic cancer. | Biochem Pharmacol | 2024 | 39214450 | PubTator, text mining | PubMed |
| Combining radiomics and molecular biomarkers: a novel economic tool to improve diagnostic ability in papillary thyroid cancer. | Front Endocrinol (Lausanne) | 2024 | 39205691 | PubTator, text mining | PubMed |
| TNF Induces Laminin-332-Encoding Genes in Endothelial Cells and Laminin-332 Promotes an Atherogenic Endothelial Phenotype. | Int J Mol Sci | 2024 | 39201392 | PubTator, text mining | PubMed |
| The extracellular matrix component perlecan/HSPG2 regulates radioresistance in prostate cancer cells. | Front Cell Dev Biol | 2024 | 39149513 | PubTator, text mining | PubMed |
| Identification of hub genes and key modules in laryngeal squamous cell carcinoma. | Transl Cancer Res | 2024 | 39145051 | PubTator, text mining | PubMed |
| LAMB3: Central role and clinical significance in neoplastic and non-neoplastic diseases. | Biomed Pharmacother | 2024 | 39111076 | PubTator, text mining | PubMed |
| Reconstruction of single-cell lineage trajectories and identification of diversity in fates during the epithelial-to-mesenchymal transition. | Proc Natl Acad Sci U S A | 2024 | 39093947 | PubTator, text mining | PubMed |
| CRABP2 promotes cell migration and invasion by activating PI3K/AKT and MAPK signalling pathways via upregulating LAMB3 in prostate cancer. | J Biochem | 2024 | 39038078 | PubTator, text mining | PubMed |
| Mini-implant assisted palate expansion and digital design in junctional epidermolysis bullosa and amelogenesis imperfecta: Case report. | Spec Care Dentist | 2024 | 39034598 | PubTator, text mining | PubMed |
| YAP-LAMB3 axis dictates cellular resistance of pancreatic ductal adenocarcinoma cells to gemcitabine. | Mol Carcinog | 2024 | 39016677 | PubTator, text mining | PubMed |
| [Single-cell transcriptomic sequencing coupled with Mendelian randomization analysis elucidates the pivotal role of CTSC in chronic rhinosinusitis]. | Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi | 2024 | 38965845 | PubTator, text mining | PubMed |
| Altered extracellular matrix correlates with an immunosuppressive tumor microenvironment and disease progression in younger adults with oral cavity squamous cell carcinoma. | Front Oncol | 2024 | 38957320 | PubTator, text mining | PubMed |
| [Clinical and bioinformatics analysis of the relationship between LAMA3 DNA methylation expression and platinum resistance and prognosis in epithelial ovarian cancer]. | Zhonghua Fu Chan Ke Za Zhi | 2024 | 38951081 | PubTator, text mining | PubMed |
| Molecular autopsy by proxy: relevance for genetic counseling in rare genetic disorders. | Front Genet | 2024 | 38859940 | PubTator, text mining | PubMed |
| Molecular Basis of Cerebral Vasospasm: What Can We Learn from Transcriptome and Temporal Gene Expression Profiling in Intracranial Aneurysm? | OMICS | 2024 | 38717843 | PubTator, text mining | PubMed |
| Of LAMA3 and LAMB3: A novel gene therapy for epidermolysis bullosa. | Mol Ther | 2024 | 38631349 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3914/papers?page=5